OTTAWA, April 14 (Reuters) - Canada's health ministry said
on Wednesday it would not restrict use of AstraZeneca PLC's
COVID-19 vaccine at this time after a review showed the
benefits outweighed the very rare risk of blood clots.
A separate advisory council had earlier recommended Canada
stop offering the vaccine to people under 55. The panel is now
reviewing that advice, the health ministry said in a statement.
(Reporting by David Ljunggren)